Calcium oxaloacetate:Exports & Compliance White Paper 2026

I. Executive Summary

Calcium oxaloacetate (CAS 1135040-86-6) is the calcium salt of oxaloacetic acid, a tricarboxylic-acid-cycle intermediate, and it is sold both as a research material and as a nutraceutical ingredient. Everything commercially distinctive about it follows from one chemical fact: oxaloacetate is a β-keto dicarboxylic acid that decarboxylates readily to pyruvate and carbon dioxide, and that reaction is accelerated by heat, moisture, low pH and divalent metal ions. Assay, shelf life and cold chain are therefore not support functions in this trade — they are the product.

The practical consequences are specific. A certificate reporting only an oxaloacetate figure is meaningless unless it also reports pyruvate and water, and preferably the metal content, because those determine how much of the nominal value survives to the customer's point of use. Solid-form control, low-temperature processing, protected packaging and validated shelf life are what separate a usable lot from a certificate. In the market this is expressed as lyophilised or refrigerated presentations and encapsulated finished formats — product positioning and handling discipline rather than a formulation recipe.

This paper covers the food-grade perimeter — EU food-supplement Directive 2002/46/EC with the novel-food assessment under Regulation (EU) 2015/2283 and the specific novel-food history for oxaloacetate, the US DSHEA framework with 21 CFR Part 111 and new-dietary-ingredient considerations, USP and FCC options, ISO 22000 and FSSC 22000, halal, kosher, vegan and non-GMO statements, REACH, CLP and TSCA — plus cold-chain logistics, shelf-life validation and the China, India and Western ecosystem. No health, longevity or disease claim is made or implied.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

Oxaloacetate is the four-carbon dicarboxylic keto acid that condenses with acetyl-CoA in the citrate synthase step of the tricarboxylic acid cycle and interconverts with malate and aspartate in central metabolism. For a manufacturer that biochemistry matters only as chemistry: it identifies the compound, and it explains why the material has to be made, isolated and shipped cold. Nothing in this paper characterises it as a therapeutic agent.

• Decarboxylation chemistry and its analytical consequences: β-Keto acids lose carbon dioxide readily, and oxaloacetate decarboxylates to pyruvate in solution and in the damp solid, faster at higher temperature and in the presence of metal ions. The specification must therefore quantify oxaloacetate and pyruvate together, typically by HPLC with UV detection or by an enzymatic malate-dehydrogenase coupled assay. Metal content is a stability parameter as well as a contaminant parameter, and any assay performed after a warm transit will flatter the seller and mislead the buyer.
• Calcium salt stoichiometry, hydrate state and solid form: Oxaloacetate is dicarboxylic, so mono- and di-calcium forms and different hydration states are possible, and the solid form governs both flow and stability. Calcium content by ICP-OES, water by Karl Fischer and XRPD or DSC for form identification belong on the certificate together. Lyophilised and crystalline presentations behave differently in packaging and in use, so the supplier must state which is supplied and validate shelf life on that presentation rather than on the other.

2.2 Synthesis and Manufacturing Technologies

As with other unstable keto acids, manufacture is two-stage: build oxaloacetate or a protected precursor, then convert to the calcium salt and isolate under conditions that do not destroy it. Two route classes dominate, described at class level only.

• Condensation route class: The classical approach condenses a dialkyl oxalate with an alkyl acetate under strong alkoxide base to give a protected oxaloacetate ester enolate, which is then hydrolysed under carefully controlled conditions — mild, cold and brief — so that the ester is cleaved without decarboxylating the product, followed by conversion to the calcium salt. The characteristic impurity set is pyruvate from over-decarboxylation, partially hydrolysed ester, oxalate and residual alcohol solvent. Temperature and residence time in the hydrolysis step are the critical process parameters.
• Biotransformation route class: The alternative oxidises L-malate using malate dehydrogenase, or transaminates aspartate using aspartate aminotransferase, with cofactor handling and, where needed, regeneration; whole-cell and isolated-enzyme variants both exist. The attraction is mild aqueous conditions that suit a labile product and the absence of strong base and organic solvent; the cost is low productivity and a downstream that must clear protein and, for sensitive uses, endotoxin. Isolation still has to be done cold, by low-temperature concentration or lyophilisation.

2.3 Core Application Matrix

• Research reagent and analytical standard: Legitimate research use covers tricarboxylic-acid-cycle and enzyme assays, metabolomics calibrants and method-development work, where the buyer needs a stated oxaloacetate content with pyruvate and water declared and a known solid form. Buyers in this channel routinely re-assay on receipt and will reject lots whose degradation profile is undocumented.
• Nutraceutical ingredient for branded finished products: Supply into the supplement channel is ingredient supply to brands and contract manufacturers, and it is dominated by the stability question: the value offered is a material that still contains what the label declares at the end of a validated shelf life. This paper makes no health, longevity or disease claim, and claims compliance rests with the brand.
• Contract development of stabilised presentations: A substantial share of business is development work: lyophilised formats, encapsulated or otherwise protected finished formats developed with the brand, alternative salt forms, and shelf-life and cold-chain validation programmes. These projects are specification- and data-driven and require a quality agreement with defined change control.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand comes from research laboratories and from supplement brands, and in both cases the purchasing decision turns on demonstrated stability rather than on nominal assay. The 2026 shift is that buyers now ask for pyruvate content, water, metal content and real-time stability data before they ask for price, and they qualify shipping performance as part of the product. Suppliers who cannot produce a lane-qualified cold-chain file are excluded before commercial discussion begins.

3.2 Capacity Distribution and Export Flows

The number of producers able to run cold hydrolysis, low-temperature isolation and lyophilisation at commercial scale is small. Synthesis and salt formation sit largely in China and India; lyophilisation, encapsulation, release testing and branded finishing sit in the European Union and the United States. Because volumes are small and unit values high, flows are dominated by air freight in insulated shippers, with sea freight used only where a validated refrigerated container and receiver capability exist.

3.3 Market Bifurcation and Pricing Dynamics

The price spread is unusually wide because it reflects two different products: material sold on a nominal assay, and material sold on a validated stability and cold-chain file. Yield loss through decarboxylation, lyophilisation cost, analytical burden and refrigerated freight all sit in the price, so quotes move more with specification than with volume. Buyers should normalise on the pyruvate and water limits and on the shipping method before comparing numbers.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

The regulatory position is food and chemical, not pharmaceutical, but instability makes it stricter than it looks: a declared content on a label must hold through the stated shelf life, so shelf-life substantiation is a compliance obligation rather than a marketing claim. The two questions that decide market access are whether oxaloacetate may lawfully be used as a food ingredient in the target market, and whether the supplier can prove the material survives its shelf life.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• Food-supplement framework and the novel-food history for oxaloacetate: Where calcium is the declared nutrient, the mineral form must be among those permitted under Regulation (EC) No 1170/2009, and the finished product must comply with food-supplement Directive 2002/46/EC, contaminant limits in Regulation (EU) 2023/915 and labelling under Regulation (EU) No 1169/2011. Oxaloacetate has its own novel-food history in the European Union: any authorisation under Regulation (EU) 2015/2283 is recorded on the Union list and is typically applicant-specific, with defined identity, specification and conditions of use, so a food business operator must verify that its material and use fall within an existing authorisation.
• REACH, CLP, food-contact materials and food-safety management: Placed on the market in its own right, the substance remains within REACH registration and CLP classification and labelling obligations with a compliant safety data sheet for industrial handling. Packaging must satisfy Regulation (EC) No 1935/2004 and the good manufacturing practice requirements of Regulation (EC) No 2023/2006, which is not trivial for an insulated shipper with phase-change material. Manufacturers are normally certified to ISO 22000 or FSSC 22000.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• Dietary-ingredient framework — DSHEA and 21 CFR Part 111: As a dietary ingredient the material falls under DSHEA: the marketer is responsible for safety and, where the ingredient is not grandfathered, for a new dietary ingredient notification, while the finished-supplement manufacturer must meet Part 111 current good manufacturing practice including identity testing on receipt and component specifications. Food facility registration and FSMA preventive controls apply alongside, and no disease claim may be made for a supplement.
• Grade standards, TSCA and state-level contaminant rules: Buyers commonly specify Food Chemicals Codex or USP grade where a specification exists, and those drive heavy-metal and assay limits in the contract. Import as a chemical substance requires the material to be listed as active on the TSCA inventory or covered by an applicable exemption. Because the compound degrades, labelled content must be supported by stability data under the labelled storage condition.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

The environmental profile has two parts: the solvent and base load of the condensation route class, and the energy cost of keeping the material cold from isolation to delivery. Cold chain is the larger and more visible of the two, and it is the part customers ask about.

5.1 Carbon Footprint and Circular Economy

Lyophilisation, refrigerated storage and air freight dominate the footprint, so the carbon profile is driven by the stability requirement rather than by the chemistry. Sites certified to ISO 14001 normally report energy per kilogram, solvent recovery and refrigerant management, and the practical levers are lyophilisation cycle optimisation, reusable insulated shippers and lane consolidation. The biotransformation route class reduces solvent load but adds a biological waste stream.

5.2 Sustainable Sourcing and Traceability

Traceability questions cover raw-material origin, non-GMO status, vegan and vegetarian status where no animal-derived processing aids are used, halal and kosher certification for brand programmes, and allergen declarations. For this molecule traceability also means temperature history: a batch record without continuous temperature documentation is incomplete, because the value of the lot depends on the conditions it has seen. ISO 22000 or FSSC 22000 certification provides the audited framework behind those statements.

VI. Supply Chain Resilience and Export Logistics

Cold chain is the central logistics fact for calcium oxaloacetate. Packaging, mode selection, lane design and receiving procedure all exist to hold one temperature range and one moisture condition, and every one of them has to be qualified rather than assumed.

6.1 Packaging Standards and Moisture/Contamination Control

• Refrigerated and lyophilised primary packaging: Typical supply is amber glass vials or foil laminate pouches with a moisture-barrier seal, dry headspace and unit sizing that avoids repeated opening. Lyophilised material is less sensitive to brief excursions than solution or damp solid, which is why it is the preferred commercial presentation. Every pack should be lot-coded with a defined storage condition and, for food-grade supply, supported by food-contact declarations under Regulation (EC) No 1935/2004 or the applicable FDA provision.
• Insulated shippers, monitoring and excursion management: Qualified insulated shippers with phase-change material or refrigerated gel packs are standard, sized to the lane rather than to the route average. Temperature logging should be continuous, with the record delivered with the lot, and the receiving procedure should specify quarantine and assessment against the stability dataset on any excursion rather than automatic acceptance or rejection. Shipper qualification should cover worst-case seasonal profiles, not only nominal transit times.

6.2 Dangerous Goods Identification and Transit Protocols

The substance itself is generally not classified as a dangerous good for transport, so the hazard in a consignment usually comes from how it is cooled rather than from what it is. Where dry ice is used, it is a Class 9 dangerous good under UN 1845 with marking, labelling and documentation obligations under IATA packing instruction 954 and the corresponding ADR and IMDG provisions. Where refrigerant gels or phase-change materials are used instead, the consignment travels as a temperature-controlled non-hazardous shipment, and air movement should follow the IATA temperature-control regulations.

VII. Enterprise Global Expansion Strategy Guide

Suppliers win here by proving stability and by owning the cold chain. Buyers are research laboratories, supplement brands and contract manufacturers, and the qualification question is always the same: will this material still contain what the certificate says when I open it.

1. Compete on demonstrated stability, not nominal assay: Publish oxaloacetate and pyruvate limits together, with water, metal content, heavy metals, microbiological criteria and residual solvent, plus a stated solid form. Validate assay methods that resolve oxaloacetate from pyruvate, and generate real-time stability data on the presentation actually sold.
2. Build the food-grade file: Verify novel-food status and any applicant-specific conditions of use before quoting into the EU; hold ISO 22000 or FSSC 22000; maintain halal, kosher, vegan, non-GMO and allergen statements with evidence; and support contaminant data with ISO/IEC 17025 third-party testing. State in writing that no health, longevity or disease claim is made and that claims compliance belongs to the brand.
3. Own the cold chain end to end: Qualify shippers by lane and season, specify dry-ice or gel systems deliberately, define excursion handling in the quality agreement, and deliver temperature records with every lot. Dual-source across regions only where the second source can meet the same cold-chain and stability file.

VIII. Conclusion

Calcium oxaloacetate is a molecule whose commercial value is created or destroyed after the synthesis is finished. The chemistry is straightforward and the route classes are established; what decides whether a supplier has a business is whether the material reaches the customer with its declared content intact, whether that can be proven with data, and whether the food-grade file supports the intended market.

Into 2026 the trends are tighter buyer specifications that name pyruvate limits explicitly, wider use of lyophilised and encapsulated presentations, more demand for lane-qualified cold-chain evidence, and continued regulatory attention to novel-food status. Organisations that invest in low-temperature processing, validated stability data and a complete certified food-grade file will hold the branded channels; those competing on nominal assay and ambient freight will not.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global Calcium oxaloacetate Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Calcium oxaloacetate supply chain:

• China — keto-acid synthesis and salt formation: Chinese producers hold the depth in the condensation route class, with alkoxide-base condensation, controlled cold hydrolysis and salt formation, and they are the price leaders for research-grade and bulk ingredient material. The best sites have added low-temperature isolation, lyophilisation and cold-chain dispatch, which determines whether they can serve branded food-grade customers.
• India — process development and biotransformation: Indian manufacturers are strongest in development work: route selection between condensation and biotransformation, salt-form screening, analytical method development for oxaloacetate and pyruvate resolution, and export documentation for EU and US customers. Their position is mid-cost with strong chemistry capability.
• European Union and United States — stabilisation, finishing and cold-chain logistics: Western participants concentrate on lyophilisation, encapsulated finished formats, release testing, ISO 22000 or FSSC 22000 certification and validated refrigerated distribution. This region also holds the ISO/IEC 17025 laboratories that verify assay and contaminant data and the brands that own claims compliance.